Total Payments
$1,178
2024 Payments
$494.90
Companies
9
Transactions
27
Medicare Patients
2,968
Medicare Billing
$283,066
Payment Breakdown by Category
Food & Beverage$1,079 (91.6%)
Education$99.00 (8.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,079 | 26 | 91.6% |
| Education | $99.00 | 1 | 8.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $332.75 | 11 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $331.86 | 3 | $0 (2024) |
| PFIZER INC. | $127.76 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $111.99 | 3 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $109.74 | 2 | $0 (2024) |
| Olympus America Inc. | $54.36 | 2 | $0 (2017) |
| Covidien LP | $50.00 | 1 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $39.47 | 3 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $20.20 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $494.90 | 8 | Phathom Pharmaceuticals, Inc. ($331.86) |
| 2023 | $144.80 | 5 | ABBVIE INC. ($144.80) |
| 2022 | $142.05 | 2 | PFIZER INC. ($127.76) |
| 2018 | $195.05 | 6 | Janssen Biotech, Inc. ($111.99) |
| 2017 | $201.33 | 6 | AbbVie, Inc. ($120.36) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $79.44 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $99.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $107.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: VIROLOGY | ||||||
| 08/16/2023 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: VIROLOGY | ||||||
| 04/03/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $89.51 | General |
| Category: IMMUNOLOGY | ||||||
| 02/21/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: VIROLOGY | ||||||
| 10/22/2022 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $127.76 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/25/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: VIROLOGY | ||||||
| 06/19/2018 | Janssen Biotech, Inc. | REMICADE (Biological) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 05/14/2018 | BOSTON SCIENTIFIC CORPORATION | SPYGLASS (Device) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: BILIARY DEVICES | ||||||
| 05/01/2018 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: Immunology | ||||||
| 04/25/2018 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: Immunology | ||||||
| 04/14/2018 | Covidien LP | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 02/28/2018 | Janssen Scientific Affairs, LLC | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 08/31/2017 | Olympus America Inc. | EVIS EXERA (Device) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: GI & Respiratory Products | ||||||
| 07/18/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - BILIARY DEVICES (Device) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: BILIARY DEVICES | ||||||
| 05/31/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $96.75 | General |
| 04/27/2017 | Olympus America Inc. | Olympus EMR & ESD Devices (Device) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: EndoTherapy Products | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 818 | 936 | $756,981 | $76,557 |
| 2022 | 15 | 816 | 942 | $702,061 | $76,420 |
| 2021 | 14 | 648 | 768 | $535,573 | $66,495 |
| 2020 | 14 | 686 | 812 | $492,543 | $63,594 |
Total Patients
2,968
Total Services
3,458
Medicare Billing
$283,066
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 113 | 145 | $64,960 | $14,083 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 143 | $48,906 | $10,948 | 22.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 37 | 40 | $131,760 | $9,022 | 6.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 71 | 73 | $216,372 | $8,539 | 3.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 60 | 61 | $110,593 | $6,011 | 5.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 52 | $26,000 | $5,918 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $26,145 | $5,658 | 21.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $18,252 | $3,246 | 17.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 44 | $12,980 | $3,045 | 23.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 11 | 11 | $25,388 | $2,215 | 8.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 11 | 17 | $25,228 | $2,115 | 8.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 34 | 35 | $6,265 | $1,517 | 24.2% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 13 | 13 | $5,954 | $1,441 | 24.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 23 | 23 | $8,096 | $1,367 | 16.9% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Facility | 2023 | 65 | 82 | $7,708 | $891.89 | 11.6% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 107 | 113 | $22,374 | $541.42 | 2.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 146 | 191 | $82,894 | $19,515 | 23.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 72 | 72 | $207,144 | $8,836 | 4.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 57 | 57 | $32,148 | $7,605 | 23.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 66 | 69 | $121,440 | $6,756 | 5.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 88 | $29,216 | $6,527 | 22.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 51 | 54 | $26,190 | $6,360 | 24.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 29 | 29 | $92,742 | $6,320 | 6.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 65 | $18,590 | $4,036 | 21.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 38 | 38 | $17,252 | $2,831 | 16.4% |
About Dr. Devi Patel, MD
Dr. Devi Patel, MD is a Gastroenterology healthcare provider based in Flemington, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2012. The National Provider Identifier (NPI) number assigned to this provider is 1053670679.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devi Patel, MD has received a total of $1,178 in payments from pharmaceutical and medical device companies, with $494.90 received in 2024. These payments were reported across 27 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,079).
As a Medicare-enrolled provider, Patel has provided services to 2,968 Medicare beneficiaries, totaling 3,458 services with total Medicare billing of $283,066. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Flemington, NJ
- Active Since 05/16/2012
- Last Updated 09/09/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1053670679
Products in Payments
- VOQUEZNA (Drug) $331.86
- XELJANZ (Drug) $127.76
- SKYRIZI (Biological) $120.02
- NUPLAZID (Drug) $109.74
- REMICADE (Biological) $99.00
- MAVYRET (Drug) $56.67
- STELARA (Biological) $33.19
- EVIS EXERA (Device) $29.93
- Olympus EMR & ESD Devices (Device) $24.43
- Humira (Biological) $23.61
- RINVOQ (Biological) $19.00
- LINZESS (Drug) $16.70
- GENERAL - POLYPECTOMY (Device) $16.20
- SPYGLASS (Device) $12.86
- GENERAL - BILIARY DEVICES (Device) $10.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Flemington
Dr. Richard Arrigo, Do, DO
Gastroenterology — Payments: $38,803
Gastroenterology $38,803
Dr. Jeffrey Hartford, M.d, M.D
Gastroenterology — Payments: $7,811
Gastroenterology $7,811
Dr. Anik Patel, M.d, M.D
Gastroenterology — Payments: $1,285
Gastroenterology $1,285
Dr. Kenneth Digregorio, M.d, M.D
Gastroenterology — Payments: $727.17
Gastroenterology $727.17
Andrea Goldstein, M.d, M.D
Gastroenterology — Payments: $642.85
Gastroenterology $642.85
Gilbert Cardoso, Do, DO
Gastroenterology — Payments: $621.85
Gastroenterology $621.85